Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What value animal experimentation.

American journal of pharmaceutical education·2010
Same author

Effect of the anesthetic and the rate of injection of digitalis upon its lethal dose in cats.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association·2010
Same author

Studies on sex difference in resistance to ouabain in the albino rat.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association·1951
Same author

Studies on tolerance and cross-tolerance to Nostal (propallylonal; isopropyl-beta-bromallyl barbituric acid.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association·1950
Same author

Comparison of analgetic activity of 67 arylalkamines with that of morphine and meperidine by the mouse hot plate method.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association·1950
Same author

Studies on sex variation to picrotoxin in the albino rat.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association·1949

Related Experiment Video

Updated: Jun 14, 2026

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

Graduate work in pharmacology

H G O HOLCK

    American Journal of Pharmaceutical Education
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    PHARMACOLOGY/teaching

    More Related Videos

    Quantifying Agonist Activity at G Protein-coupled Receptors
    11:45

    Quantifying Agonist Activity at G Protein-coupled Receptors

    Published on: December 26, 2011

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    Novel Apparatus and Method for Drug Reinforcement
    07:32

    Novel Apparatus and Method for Drug Reinforcement

    Published on: August 20, 2010

    Quantifying Agonist Activity at G Protein-coupled Receptors
    11:45

    Quantifying Agonist Activity at G Protein-coupled Receptors

    Published on: December 26, 2011